NCT06435897View on ClinicalTrials.gov

Autoimmune Disease Treatment With Mesenchymal Stem Cells (MSCs) and CAR-T Cells

PHASE1/PHASE2RecruitingINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

May 15, 2024

Primary Completion Date

July 15, 2027

Study Completion Date

December 31, 2027

Conditions
Autoimmune Diseases
Interventions
BIOLOGICAL

fetal MSCs combined with 4SCAR T cells

Infusion of 4SCAR T cells at 10\^6 cells/kg body weight and MSCs at 3x10\^6 cells via IV

Trial Locations (1)

518000

RECRUITING

Shenzhen Geno-immune Medical Institute, Shenzhen

All Listed Sponsors
lead

Shenzhen Geno-Immune Medical Institute

OTHER